Vigilant Biosciences

Vigilant Biosciences Launches Clinical Studies of Oral Cancer Assay

Vigilant Biosciences has launched patient enrollment for clinical studies of its OncAlert point-of-care qualitative...

Survey Reports That Patients Want Oral Cancer Screenings and Education

More than 49,750 people in the United States will be diagnosed with oral cancer...

Awareness Is the Key to Fighting Oral Cancer

April is Oral Cancer Awareness Month, and dentistrytoday.com will be celebrating the event with...

Oral Cancer Test Gets European Conformity (CE) Mark

Vigilant Biosciences has received the European Conformity (CE) mark for its OncAlert Oral Cancer...

Statistics Alone Don’t Reveal Oral Cancer’s Terrible Toll

While many of us may have heard the horrific statistics associated with oral cancer,...

Patients Want More Oral Cancer Education

Despite the dental community’s educational efforts during Oral Cancer Awareness Month each April, 58%...

Cancer Detection Tool Earns CE Mark

The OncAlert Oral Cancer CD44/Total Protein LAB Test from Vigilant Biosciences now has the...

Personal Journey Drives Cancer Innovation

Today’s oral cancer detection products typically rely on revealing abnormalities or detecting HPV. Yet...

Companies Ink Deal for Oral Cancer Detection Products

Vigilant Biosciences has struck a three-year deal with Crown Dental + Medical Limited to distribute...